Published in Exp Hematol on February 01, 1991
Tumor necrosis factor alpha promotes replication and pathogenicity of rat cytomegalovirus. J Virol (1994) 1.05
Synergistic effect of IL-4 and TNF-alpha in the induction of monocytic differentiation of a mouse myeloid leukaemic cell line (WEHI-3B JCS). Immunology (1994) 0.75
IL-1β and Caspase-1 Drive Autoinflammatory Disease Independently of IL-1α or Caspase-8 in a Mouse Model of Familial Mediterranean Fever. Am J Pathol (2016) 0.75
A role for interferon-gamma and transforming growth factor-beta in erythroid cell-mediated regulation of nitric oxide production in macrophages. Immunology (1997) 0.75
Expression of differentiated functions in mouse neuroblastoma mediated by dibutyryl-cyclic adenosine monophosphate. Nature (1971) 1.87
A rapid and efficient method for testing immunohistochemical reactivity of monoclonal antibodies against multiple tissue samples simultaneously. J Immunol Methods (1987) 1.52
Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA. Nature (1995) 1.48
Prognostic value of estrogen receptor determinations in patients with breast cancer. Cancer Res (1978) 1.29
Growth of Escherichia coli on fatty acids: requirement for coenzyme A transferase activity. Biochem Biophys Res Commun (1968) 1.08
Inhibition by 2',3'-dideoxythymidine of retroviral infection of mouse and human cells. Cancer Lett (1980) 1.08
The prognostic value of estrogen receptor determinations in patients with primary breast cancer: an update. Cancer (1980) 1.08
Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice. Cancer Res (1994) 1.05
Growth of human mammary epithelial cells on collagen gel surfaces. Cancer Res (1981) 0.99
Cell surface interactions with concanavalin A. Location of bound radiolabeled lectin. Exp Cell Res (1974) 0.97
Antitumor effects of recombinant human interleukin 1 alpha in RIF-1 and Panc02 solid tumors. Cancer Res (1988) 0.94
Concanavalin A-mediated hemadsorption by normal and malignant human mammary epithelial cells. Cancer Res (1978) 0.94
Absence of fibronectin and presence of plasminogen activator in both normal and malignant human mammary epithelial cells in culture. J Cell Biol (1980) 0.93
Growth of normal and malignant human mammary epithelial cells in culture. J Natl Cancer Inst (1979) 0.92
Selection of mutants constitutive for several glyoxylate condensing enzymes during growth on valeric acid. Biochim Biophys Acta (1967) 0.91
Spontaneous regression of Friend virus-induced erythroleukemia. III. The role of macrophages in regression. J Immunol (1978) 0.90
Infection of macrophages with Friend virus: relationship to the spontaneous regression of viral erythroleukemia. Cell (1979) 0.90
High-level conjugation of chelating agents onto immunoglobulins: use of an intermediary poly(L-lysine)-diethylenetriaminepentaacetic acid carrier. Biochim Biophys Acta (1986) 0.88
Normal human mammary cells in culture: evidence for oncornavirus-like particles. J Natl Cancer Inst (1974) 0.87
Influence of lactoferrin feeding and injection against systemic staphylococcal infections in mice. J Appl Microbiol (1999) 0.87
A murine model system for the study of the human leukemia-associated inhibitory activity. Blood (1980) 0.86
1H-NMR relaxation times and water compartmentalization in experimental tumor models. Magn Reson Imaging (1986) 0.86
The measurement of extracellular water volumes in tissues by gadolinium modification of 1H-NMR spin lattice (T1) relaxation. Magn Reson Imaging (1986) 0.86
Effects of dimethylsulfoxide on expression of differentiated functions in mouse neuroblastoma. J Natl Cancer Inst (1972) 0.86
Induction of leukemia regression in mice by immunotherapeutic transfer of T-lymphocytes. Cancer Res (1986) 0.86
Prognostic value of concanavalin A reactivity of primary human breast cancer cells. Cancer Res (1981) 0.86
Function of the glyoxylate-condensing enzymes. I. Growth of Escherichia coli on n-valeric acid. J Bacteriol (1967) 0.85
Presence of a mouse mammary tumor virus-related antigen in human breast carcinoma cells and its absence from normal mammary epithelial cells. J Natl Cancer Inst (1978) 0.85
Interleukin-1 alpha-induced tumour pathophysiologies can be exploited with bioreductive alkylating agents. Int J Radiat Biol (1991) 0.84
Identification and isolation of the major core protein from the oncornavirus-like particle in human milk. Cancer Res (1976) 0.83
31P-nuclear magnetic resonance studies of the effect of recombinant human interleukin 1 alpha on the bioenergetics of RIF-1 tumors. Cancer Res (1989) 0.82
Cell fusion in tumor development and progression: occurrence of cell fusion in primary methylcholanthrene-induced tumorigenesis. Int J Cancer (1989) 0.81
Spontaneous regression of friend virus induced leukemia: coinfection with regressing and conventional strains of virus. Science (1975) 0.81
Effect of the extracellular matrix on plasminogen activator isozyme activities of human mammary epithelial cells in culture. Mol Cell Biol (1983) 0.81
In vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNF-alpha): reversal with exogenous erythropoietin (EPO). Exp Hematol (1990) 0.80
In vivo hematopoietic effects of tumor necrosis factor-alpha in normal and erythroleukemic mice: characterization and therapeutic applications. Blood (1988) 0.80
Initial clinical evaluation of radiolabeled MX-DTPA humanized BrE-3 antibody in patients with advanced breast cancer. Clin Cancer Res (1998) 0.79
Inhibition of normal erythropoiesis in mice with Friend virus induced erythroleukemia. Exp Hematol (1982) 0.79
Effect of conjoint administration of tamoxifen and high-dose radiation on the development of mammary carcinoma. Int J Radiat Oncol Biol Phys (1993) 0.79
Differentiation of normal human mammary epithelial cells in culture: an ultrastructural study. Am J Anat (1976) 0.79
Effects of thymectomy and antithymocyte serum on spontaneous regression of Friend virus-induced erythroleukemia. J Natl Cancer Inst (1976) 0.79
Iron-induced conformational change in human lactoferrin: demonstration by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and analysis of effects of iron binding to the N and C lobes of the molecule. Electrophoresis (1994) 0.79
Absence of tumorigenicity in athymic mice by normal human epidermal keratinocytes after culture in serum-free medium. Cancer Lett (1992) 0.79
Lymphokine-activated killer cell plus recombinant interleukin-2 therapy of erythroleukemia in mice. Leukemia (1989) 0.79
Acute hemorrhagic necrosis of tumors induced by interleukin-1 alpha: effects independent of tumor necrosis factor. J Natl Cancer Inst (1991) 0.78
Mechanism of macrophage reversal of Friend erythroleukemia: macrophage regulation of normal and leukemic erythropoiesis. Cancer Res (1986) 0.78
Enhanced lung colonization and tumorigenicity of fused cells isolated from primary MCA tumors. Cancer Lett (1990) 0.78
Spontaneous regression of Friend virus-induced erythroleukemia. I. The role of the helper murine leukemia virus component. J Exp Med (1977) 0.77
Radioimmunolocalization of metastatic breast carcinoma using indium-111-methyl benzyl DTPA BrE-3 monoclonal antibody: phase I study. J Nucl Med (1993) 0.77
Potentiation of interleukin 1 alpha mediated antitumor effects by ketoconazole. Cancer Res (1990) 0.77
Potentiation by interleukin 1 alpha of cisplatin and carboplatin antitumor activity: schedule-dependent and pharmacokinetic effects in the RIF-1 tumor model. Cancer Res (1994) 0.77
Synergistic enhancement by interleukin-1 alpha of cisplatin-mediated antitumor activity in RIF-1 tumor-bearing C3H/HeJ mice. Cancer Chemother Pharmacol (1993) 0.77
Cell surface interactions with concanavalin A: determination by microhemadsorption. Proc Soc Exp Biol Med (1972) 0.77
Potentiation of mitomycin C and porfiromycin antitumor activity in solid tumor models by recombinant human interleukin 1 alpha. Cancer Res (1991) 0.76
Spontaneous regression of Friend virus-induced erythroleukemia. VI. Structural and antigenic differences between the regressing and conventional strains of virus. J Virol (1980) 0.75
The effect of adrenalectomy and dexamethasone on interleukin-1 alpha induced responses in RIF-1 tumours. Br J Cancer (1990) 0.75
An ultrastructural study of normal human mammary epithelial cells in culture. Am J Anat (1975) 0.75
Effects of inhibitors and activators of protein kinase C on late erythroid progenitor (CFU-e) colony formation in vitro. Int J Cell Cloning (1989) 0.75
Induction of lactoferrin expression in murine ES cells by retinoic acid and estrogen. Exp Cell Res (1998) 0.75
Pharmacokinetics, biodistribution, and gamma camera imaging of 111In-KC-4G3 murine monoclonal antibody in athymic nude mice with or without human tumor xenografts. Cancer Res (1990) 0.75
Spontaneous regression of Friend murine leukemia virus-induced erythroleukemia. V. Cell-mediated antivirus immunity in mice undergoing erythroleukemia regression and in leukemic mice. J Natl Cancer Inst (1980) 0.75
Stimulation of normal erythropoiesis in vitro by macrophages from erythroleukemic mice. J Natl Cancer Inst (1984) 0.75
Infection of haematopoietic stem cells in mice with Friend virus induced erythroleukaemia. Cell Tissue Kinet (1986) 0.75
Immunotherapeutic approaches to leukemia: the use of the Friend virus-induced erythroleukemia model system. Cancer Res (1990) 0.75
Iron binding to human lactoferrin alters reactivity of the protein with plant lectins. Biochem Biophys Res Commun (1993) 0.75
Spontaneous regression of Friend virus-induced erythroleukemia IX. Role of complement in leukemia regression. Leuk Res (1982) 0.75
Spontaneous regression of Friend-virus-induced erythroleukemia. VII. The genetic control of regression. Int J Cancer (1981) 0.75
The etiology of breast cancer. Curr Top Mol Endocrinol (1976) 0.75
In vitro studies on the mechanism of action of hepsulfam in chronic myelogenous leukemia patients. Cancer Res (1990) 0.75
An analysis of factors associated with non-compliance with follow-up recommendations after a positive fecal occult blood test. Prog Clin Biol Res (1989) 0.75
Results of a preliminary "blind" study on the presence of the human tumor nucleolar antigen in breast carcinomas, benign breast tumors, and normal breast tissues. Clin Immunol Immunopathol (1981) 0.75
The role of interferon in the spontaneous regression of Friend virus induced leukemia. Proc Soc Exp Biol Med (1975) 0.75
Effect of high-dose, fractionated local irradiation on MNU-induced carcinogenesis in the rat mammary gland. Carcinogenesis (1995) 0.75
Induction of permanent regression of Friend virus (FV) leukemia by adoptive transfer of T helper and not T cytotoxic cells. Leuk Res (1992) 0.75
Penetration of cells into Millipore diffusion chambers. Exp Cell Res (1977) 0.75
Inhibition of CFU-E colony formation by resident peritoneal macrophages from hybrids of BALB/c mice. J Leukoc Biol (1984) 0.75
Results of a community-based breast cancer screening program. Prog Clin Biol Res (1989) 0.75
Effect of C-reactive protein on granulocyte-macrophage progenitor cells. J Lab Clin Med (1982) 0.75
Differential effect in vitro of tumor necrosis factor-alpha (TNF) on normal and virus-infected erythroid progenitors from Friend virus (FVA)-infected mice. Exp Hematol (1992) 0.75
SIM and SIM.R mice are histoincompatible. Virology (1978) 0.75
Radioimmunolocalization of breast cancer using BrE-3 monoclonal antibody. Adv Exp Med Biol (1994) 0.75
Spontaneous regression of Friend virus-induced erythroleukemia-VIII. Humoral immune reactivity in regressed and leukemic mice. Leuk Res (1981) 0.75
Spontaneous regression of Friend murine leukemia virus-induced erythroleukemia. IV. Effects of radiation and athymia on leukemia regression in mice. J Natl Cancer Inst (1979) 0.75
Radiosensitization of tumor-targeted radioimmunotherapy with prolonged topotecan infusion in human breast cancer xenografts. Cancer Res (2001) 0.75
In vivo effects of recombinant human and murine interleukin-1 alpha (IL-1 alpha) on murine hematopoiesis. In Vivo (1991) 0.75
The effect of continuous infusion IL-1 alpha on carboplatin-induced thrombocytopenia and anti-tumor activity in RIF-1 tumor bearing mice. Oncol Rep (2011) 0.75
Spontaneous regression of Friend virus-induced erythroleukemia. II. regression of Friend murine leukemia virus-induced lymphocytic leukemia. J Natl Cancer Inst (1977) 0.75
Biologic activity of interleukin 1 (IL-1) alpha in patients with refractory malignancies. J Immunother (1998) 0.75